Glimtoss PZ 2mg/500mg/15mg Tablet
Marketer
Astonea Labs Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimtoss PZ 2mg/500mg/15mg Tablet
Combiflex DM 2mg/500mg/15mg tablets offer a triple-action approach to managing blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, thus reducing elevated blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex DM 2mg/500mg/15mg tablets. Taking it with food minimizes potential stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; in that case, skip the missed dose and resume your regular schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol consumption, or meal skipping increases the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, patients with kidney, liver, or heart conditions should consult their doctor. Pregnant or lactating women should also seek medical advice. Kidney function tests will be assessed by your doctor before initiating therapy. Limit alcohol consumption as it may exacerbate side effects.
Primary Ingredients of Glimtoss PZ 2mg/500mg/15mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Glimtoss PZ 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimtoss PZ 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glimtoss PZ 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Glimtoss PZ 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimtoss PZ 2mg/500mg/15mg Tablet:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimtoss PZ 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Glimtoss PZ 2mg/500mg/15mg Tablet works:
Glimtoss PZ 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged approach: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimtoss PZ 2mg/500mg/15mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimtoss PZ 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Glimtoss PZ 2mg/500mg/15mg tablets is likely unsafe. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimtoss PZ 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimtoss PZ 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimtoss PZ 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimtoss PZ 2mg/500mg/15mg Tablet :
Should you forget a Glimtoss PZ 2mg/500mg/15mg Tablet dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimtoss PZ 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Medication for diabetes |
3,018 People bought this recently